Circulation
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT).
A low level of HDL cholesterol has been identified as a risk factor for stroke in observational studies. ⋯ In men with coronary heart disease, low HDL cholesterol, and low LDL cholesterol, gemfibrozil reduces stroke incidence.